Skip to main content Help with accessibility Skip to main navigation

TILDRAKIZUMAB solution for injection (Ilumetri®▼) for moderate to severe plaque psoriasis

CCG Approval Status:

Date Added: 20 - Aug - 2020
Body System:
Red

The Pan Mersey Area Prescribing Committee recommends the prescribing of TILDRAKIZUMAB solution for injection (Ilumetri®▼), by specialists only, for moderate to severe plaque psoriasis in accordance with NICE TA575.